Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.059 AUD | -6.35% | -6.35% | -1.67% |
Feb. 25 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Jan. 19 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Sales 2022 | 446K 298K | Sales 2023 | 149K 99.66K | Capitalization | 13.88M 9.27M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.34M | Net income 2023 | -3M -2M | EV / Sales 2022 | 37.7 x |
Net cash position 2022 | 6.34M 4.24M | Net cash position 2023 | 2.99M 2M | EV / Sales 2023 | 72.9 x |
P/E ratio 2022 |
-6.84
x | P/E ratio 2023 |
-4.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.93% |
1 day | -6.35% | ||
1 week | -6.35% | ||
Current month | -6.35% | ||
1 month | -14.49% | ||
3 months | +40.48% | ||
6 months | +15.69% | ||
Current year | -1.67% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Grogan
CEO | Chief Executive Officer | - | 23-08-27 |
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sarah Driessens
LAW | General Counsel | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Andrew Guthrie
BRD | Director/Board Member | - | 21-04-25 |
Alex Ding
CHM | Chairman | - | 23-05-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 0.059 | -6.35% | 20 577 |
24-05-31 | 0.063 | 0.00% | 10,315 |
Delayed Quote Australian S.E., June 03, 2024 at 01:41 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.67% | 8.42M | |
+15.59% | 38.99B | |
-.--% | 11.36B | |
-5.61% | 7.61B | |
+3.82% | 6.45B | |
-4.57% | 6.17B | |
-4.19% | 5.73B | |
+31.35% | 5.25B | |
-12.91% | 5.23B | |
-10.02% | 4.58B |
- Stock Market
- Equities
- BGT Stock